The transcription factor GATA-6 is known to be a critical determinant of early vertebrate development. We have shown previously that mammalian GATA-6 genes have the potential to encode two protein isoforms, resulting from alternative, in-frame, initiator methionine codons. We have generated GATA-6 antibodies, including one specific to the longer form of GATA-6, and by immunohistochemical analysis we demonstrate here that the longer protein, which is the more potent transcriptional transactivator, is widely expressed in vivo. In accordance with previous RNA expression studies, GATA-6 protein was found to be abundant within regions of the gut and pulmonary systems, in addition to the heart myocardium. We also report novel GATA-6 expression within sites of chondrogenesis derived from cranial neural crest and sclerotomes. Surprisingly however, levels of GATA-6 protein were substantially reduced within the endocardial cushions and outflow tract of the heart. These are regions which express the highest levels of GATA-6 RNA within the heart. q
Results and discussion
In vertebrates, the GATA family of transcription factors comprises at least six members and GATA-4, -5 and -6 represent a sub-family which display partially overlapping expression domains, predominantly within the developing heart and endodermal derivatives. The expression domains described for GATA-4, -5 and -6 however are based upon their RNA profiles, as determined by in situ hybridization and/or Northern blotting (Arceci et al., 1993; Morrisey et al., 1996 Morrisey et al., , 1997 Brewer et al., 1999) , as studies of their protein expression patterns have not yet been described.
Within the prospective cardiac splanchnic mesoderm GATA-4, -5 and -6 RNAs are apparent from the earliest time of its specification (for review see , and their role as important transcriptional regulators within the heart is becoming clear (for review see Molkentin, 2000) . Outside of the heart field, members of the GATA 4/5/6 family are also responsible for the regulation of several gut and lung epithelia-associated genes (Molkentin, 2000; Liu et al., 2002) . It has been previously reported that the GATA-4, -5 and -6 proteins all align to their N-termini such that all polypeptides begin with the amino acid motif, MYQ (Jiang and Evans, 1996) , giving rise, in mice, to proteins of 48, 42 and 45 kDa respectively (Arceci et al., 1993; Morrisey et al., 1996 Morrisey et al., , 1997 . More recently however, we have shown that the human and mouse genes both have the potential to encode a larger GATA-6 protein by virtue of an in-frame, upstream, alternative methionine initiator codon (Brewer et al., 1999) . The protein generated by the use of this methio-nine would be approximately 15 kDa (or 33%) larger than that previously described. We demonstrated that in vitro, both the longer and shorter forms of the protein could be made, and by transfection assays we showed that the longer protein was a more potent transactivator of an artificial GATA-responsive promoter (Brewer et al., 1999) . Because of the lack of appropriate antibodies however, it has not been apparent up to now whether the longer GATA-6 isoform is made in vivo. Moreover, much of the published over-expression studies to date have assayed the function of solely the shorter GATA-6 isoform (Gove et al., 1997; Laverriere et al., 1994; Jiang and Evans, 1996) , and in many other cases it is not apparent which GATA-6 isoform is being over-expressed (Al azzeh et al., 2000; Shaw-White et al., 1999; Perlman et al., 1998; Bruno et al., 2000; Di Lisi et al., 1998; Morrisey et al., 1996) .
To address this question, we have therefore generated antisera to a region specific to the longer form of the mouse GATA-6 isoform, in addition to antisera which recognize regions common to both isoforms. We have performed a detailed study of the staining patterns of these antisera in order to determine whether the pattern of expression of GATA-6 protein mirrors that described for the RNA. Furthermore, by comparing the staining patterns generated by the different antisera we have been able to determine whether the longer GATA-6 isoform is generated in vivo.
1.1. Generation of antisera specific for the longer form of GATA-6
In order to determine whether the novel, longer GATA-6 protein isoform is expressed in vivo, we generated a polyclonal antibody, specific to the 146-amino-acid domain which is only present in the longer polypeptide (region A in Fig. 1 ). The specificity of this antibody was confirmed by immunoprecipitation with radiolabelled mouse GATA-6 polypeptides produced in vitro. As shown in Fig. 1 , antisera A immunoprecipitated only the longer polypeptide, resulting from the more upstream initiator methionine (MALT), whereas long and short GATA-6 species were detected by antisera raised to a region common to both isoforms (region B in Fig. 1 ). We therefore used our long-form-specific antibody (A) to immunostain mouse embryo sections to determine the expression patter of the longer form. Generally, alternate sections were stained with a C-terminal antibody (C in Fig. 1 ), whose specificity has been described previously . In this way we could compare the pattern of expression specifically of the longer GATA-6 protein, with that of both GATA-6 isoforms.
Wherever studied our staining patterns with the two antisera were found to be qualitatively identical, thus we demonstrate here that in vivo the longer form of mouse GATA-6 is expressed in all tissues in which we can detect any GATA-6 protein. Furthermore, within both embryonic and adult heart we show that only the longer protein isoform is evident. Therefore it is clear that GATA-6 comprises a substantially larger protein than previously has been appreciated. This should be taken into consideration, when evaluating previous data regarding the function of GATA-6, where only the shorter form has been tested, or where it is unclear which form has been ectopically expressed.
Expression of GATA-6 in early pre-implantation embryos
We have previously shown that GATA-6 RNA can be detected in extraembryonic endoderm and that this expression may be the cause of embryonic lethality in GATA-6 null mutants shortly after implantation . For this reason, we first investigated the expression of GATA-6 protein in day-7 mouse embryos using the longform specific antisera. Expression was seen in the outer margins of the decidua and also close to the avascular region bordering the yolk sac cavity ( Fig. 2A) while decidual cells between these domains did not express GATA-6 protein.
A. Brewer et al. / Mechanisms of Development 119S (2002) S121-S129 S122 Fig. 1 . Illustration of the GATA-6 regions used to produce antisera and confirmation of specificity by immunoprecipitation. The upper panel shows the regions used to produce three of the different antisera used in this study in relation to the alternative methionine initiator codons and the zinc fingers. The lower panel shows immunoprecipitations of in vitro translated mouse GATA-6 polypeptides using antisera to regions A and B. The long GATA-6 isoform, corresponding to initiations from MALT, is recognized by both antisera, whereas only antisera directed region B recognizes the short GATA-6 isoform, initiating from MYQ. We have previously shown using a lacZ knock-in that GATA-6 can also be detected in the decidua surrounding 7-day mouse embryos .
On examination of the embryos, no GATA-6 protein could be detected within the embryos proper although the parietal extraembryonic endoderm component of Reichert's membrane was strongly labeled (Fig. 2B) . This is also consistent with our previous observations of GATA-6/lacZ mice at this stage of development . Thus the long form of GATA-6 is expressed from very early stages in development.
GATA-6 expression in the embryonic heart
Many previous studies on GATA-6 RNA have focused on its expression during cardiogenesis and thus we initially analysed the distribution of GATA-6 immunoreactivity within the developing heart. Incubating serial heart sections from day-11.5 and -12.5 mouse embryos with our different anti-GATA-6 antisera reveal no obvious difference between the staining patterns (compare panels A and B in Fig. 3 ) although antisera A yielded more perinuclear staining. Both label the myocardium of the atria and ventricles. Thus the longer GATA-6 protein is expressed in vivo. We assume that the staining of blood cells with the antisera specific for the long form of GATA-6 (see, for example, Fig. 3, panel B , within the atria) is artefactual. This is based on the premise that any GATA-6 isoforms initiating from the MALT motif should also stain with the antisera directed against B and C polypeptides (Fig. 1) . With the exception of blood, this was found to be the case in all other expression domains. Although the presence of a novel, blood-specific isoform of GATA-6 cannot be excluded, we believe it is more likely that the staining seen is due to the unpurified nature of the antiserum. Surprisingly, however, both the atrioventricular (AVC in Fig. 3A ,B) and outflow tract (OTC in Fig. 3C -E) endocardial cushions are only very weakly stained with either antisera. This is in contrast to our previous observations (Brewer et al., 1999) where we demonstrated that the endocardial cushions express much higher levels of GATA-6 mRNA than the myocardium at these stages. Similarly, in that report we showed that the distal outflow tract is also a region where GATA-6 mRNA levels are particularly high, whereas here it is clear that not only is GATA-6 protein present at much lower levels (if at all) in this region, but there is a sharp boundary of expression at the distal border of the ventricle at the sinotubular junction (see Fig. 3F and arrows in Fig. 3G ). By embryonic day 12.5, spiral septation of the outflow tract has proceeded sufficiently to separate the proximal part of the ascending aorta (AsAo) and future pulmonary trunk (PT). Both of these structures lack strong GATA-6 immunoreactivity ( Fig. 3F,G) . Again, this is in contrast to previous reports from both ourselves (Brewer et al., 1999) and others (Morrisey et al., 1996) on the distribution of GATA-6 RNA in this region of the heart.
The relative lack of GATA-6 protein is also evident in derivatives of the endocardial cushions and the more developed outflow tract at later embryonic stages (Fig. 4) . Thus in day-15.5 embryos we find depleted levels of protein in the membranous part of the interventricular septum (asterisk in The outflow tract also continues to be largely unstained at this stage: by now, the truncoconal swellings have fused to form the spiral septum (SS) which has divided the pulmonary and aortic outflow tracts and both demonstrate much less immunoreactivity than the myocardium (PT and AsAo in Fig. 4B ). The maintained reduction of GATA-6 protein in both the outflow tract and derivatives of the endocardial cushions strongly suggest that the disparity between protein and RNA expression in these tissues is not simply due to In addition to the AVC, the outflow tract endocardial cushions (OTC) also lack GATA-6 staining, shown at higher magnifications in (D-F), the atria and right ventricle (RV) of 12.5-day mouse embryos continue to express high levels of GATA-6 while the ascending aorta (AsAo) and pulmonary trunk (PT) are unlabelled. (G) Higher magnification of (F). A sharp boundary of expression is seen (arrows) at the edge of the myocardium where the aortic sac begins.
temporal differences between the initiation of RNA expression and subsequent translation. It is intriguing that we detect discrete areas of substantially weaker cardiac expression within the myocardium of day-15.5 embryos which is consistent with regions involved in the developing conduction system of the heart (Fig. 4E) . The conduction system forms from an atrio-ventricular bundle (also referred to as the bundle of His), within the interventricular septum, which splits into right and left branches in order to enter the respective ventricles. We find a region within the body of the muscular part of the interventricular septum which displays much weaker immunoreactivity than the surrounding myocardium (double arrows in Fig. 4E ), which we attribute to the bundle of His, close to (or at) the division into the right and left branches. Secondly, a stripe of weakly-expressing GATA-6 cells can also be seen within the left ventricular wall (Fig.  4E, single arrow) . The location and appearance of this band of tissue is suggestive of the continuation of the left branch of the conductive bundle within the ventricular wall, known as the Purkinje system. The ontogeny of the conductive system of the heart is controversial but some elements are thought to be derived from the endocardial cushions and this may be related to the lack of GATA-6 protein expression seen here. Whether these regions express GATA-6 RNA, however, is not known and confirmation of their identity is currently being determined.
As was found to be the case in the earlier embryonic sections, the staining patterns of the hearts at these later stages were equivalent with both antisera A and C (Figs. 1 and 4, and data not shown). Thus the longer form of the protein may be the only species expressed within the heart. We therefore performed Western blots upon samples isolated from both embryonic and adult hearts, using an antibody which should recognize both long and short forms of the protein, in order to determine whether the shorter form of GATA-6 was expressed at all in these samples. Neither antibody B or C (Fig. 1) were found to immunoblot successfully, thus we made use of an additional antibody, raised against a C-terminal peptide of rat GATA-6 whose specificity and use in Western blot analysis has been described previously (Nakagawa et al., 1997) . In vitro-translated, full length human GATA-6 was run as a control. As stated previously, both long and short forms are generated in vitro, and we have previously found these to run identically to the mouse GATA-6 proteins (data not shown). However, only a single species, which co-migrates with the longer form of the in vitro-translated sample (MALT, Fig. 5 ), is evident in either the embryonic or adult heart samples. Adult brain, which does not express GATA-6 RNA (Morrisey et al., 1996) , was run as a negative control. Thus these data are consistent with the longer GATA-6 protein being the only species expressed in the heart in vivo. This strongly 5 . Detection of full length GATA-6 in adult and embryonic mouse tissues by Western blotting. (A) GATA-6 protein was detected in extracts from adult and 16.5 days post coitum mouse tissues, using Western blotting with an antibody raised against a C-terminal peptide corresponding to the rat sequence. The long form of GATA-6 was detected in both adult and embryonic mouse heart samples but was absent from adult mouse brain where RNA transcripts have not been detected by in situ hybridization or RNase protection analysis (data not shown). A number of weak, fastermigrating protein bands were detected, one of which ran at the same position as the shorter isoform of the protein (MYQ). (B) In vitro translated 35 Slabelled human GATA-6 was run on the same gel to confirm the positions of the two isoforms.
suggests that the perinuclear staining seen with the longer form-specific antisera does not indicate that this GATA-6 species is non-functional (at least in the samples additionally analysed by Western blotting). Furthermore, in all embryo sections tested, the staining pattern of the longform specific antisera (A in Fig. 1 ) was always equivalent to that of antisera C. Thus only the staining patterns generated by antisera A are shown in Figs. 6-9. Fig. 6 . GATA-6 protein is associated with branching of the bronchial tree. Sections illustrating association of GATA-6 with the respiratory system at embryonic days 11.5 (A,B) and 15.5 (C). (A) Transverse section demonstrating that the tracheal epithelium (Tr) is unlabelled in contrast to oesophageal epithelium (Oes). Also seen in this section are the labelled right (RA) and left (LA) atria. Note that the thoracic aorta (Ao) is also unlabelled. (B) Section taken caudal to (A). At this level, the trachea has bifurcated and the section includes the developing lung buds surrounding the principal bronchi (Br). The epithelia of these bronchi express GATA-6 while pulmonary vessels (PV) within the lung bud mesenchyme do not. (C) Sagittal section through the developing right lung at embryonic day 15.5. GATA-6 immunoreactivity is seen to be associated with the epithelia of the segmental bronchi (Br) while the lobar bronchi (black arrows) are negative. The transition between lobar and branching segmental bronchi (white arrows) is accompanied by the appearance of GATA-6. Fig. 7 . GATA-6 expression in the foregut. Transverse sections through the foregut at embryonic day 12.5. (A) Section through the gastro-oesophageal junction. Labelling can be seen in the oesophageal epithelium (Oes) but not in the epithelium lining the lumen (L) of the stomach. Labelling can also be seen in the investing circular smooth muscle (SM) although expression decays in more caudal elements. (B) Section taken rostral to (A). Staining of the epithelial lining of the oesophagus is evident together with continuous labelling of its associated circular smooth muscle. Fig. 8 . Association of GATA-6 with chondrogenic elements. Sections through embryos at days 11.5 (A) and 12.5 (B,C). (A) Illustration of GATA-6 positive cells (arrow) in the head mesenchyme and between ventricles III and IV. The expression pattern of GATA-6 is coincident with that of cranial neural crest and this is supported by the observations that by day 12.5 (B), GATA-6 is associated with pre-cartilaginous primordia in the first branchial arch (BAI) and the lateral regions of the nasal process (NP). The heart (H) and principal bronchus (Br) are also seen labelled in (B). (C) GATA-6 staining is also seen more caudally in sagittal sections and is associated with the notochord (N) and the sclerotome (S). Elements of midgut epithelia (G) are also seen labelled here.
Disparity between GATA-6 RNA and protein expression domains
An unexpected finding from our immunocytochemical data is the failure to detect abundant GATA-6 protein in some cardiac regions which had previously been shown to express high levels of GATA-6 RNA by in situ hybridization. Thus the cardiac outflow tract, endocardial cushions and thoracic aorta all appeared to contain no (or very little) GATA-6 protein (Brewer et al., 1999; Morrisey et al., 1996) . We are confident that this finding is not an artifact of the antibodies used since a similar pattern of staining was seen using two different antisera recognizing different domains of the GATA-6 protein. In addition we have repeated these experiments using a third GATA-6-specific antibody (antibody B in Fig. 1) , with identical results (data not shown). Moreover, staining of these regions was readily detected with other, unrelated antisera, demonstrating that they were not immunochemically unreactive tissues in our hands. As stated previously, the lack of GATA-6 protein in the cells of these regions is maintained between at least day 11.5 and their derivatives at day 15.5. Therefore the disparity between RNA and protein expression in these tissues cannot simply reflect the temporal difference between RNA transcription and subsequent translation.
There are, however, several possibilities to account for the difference between the expression domains. These include post-transcriptional regulation, alternative mRNA splicing and rapid degradation of the GATA-6 protein.
These possibilities are currently being investigated.
Whatever mechanism is responsible, the very sharp boundary of protein expression observed between the ventricular myocardium and the aortic sac at the distal limit of the outflow tract cushions (see Fig. 3F and arrows in Fig. 3G ), suggests that whatever is the underlying reason for the difference between RNA and protein expression in this region, it is subject to very strict regulation.
1.5. GATA-6 expression in the embryonic vasculature GATA-6 RNA has previously been reported to be expressed within the smooth muscle of the walls of the major blood vessels within mouse embryos (Morrisey et al., 1996) . However, as demonstrated above, the ascending aorta (AsAo) is unlabelled with anti-GATA-6 antisera up to (at least) embryonic day 12.5 ( Fig. 3F,G) although a low level of expression can be detected in day-15.5 embryos. Thus as the ascending aorta leaves the septated truncus arteriosus at embryonic day 15.5, it can be seen that GATA-6 levels are above background, though still much lower than the myocardium at this stage (Fig. 4A,B) . The future pulmonary trunk (PT) was consistently unlabelled with all GATA-6 antisera (Figs. 3F, G and 4A, B) and no pulmonary vessels demonstrated GATA-6 immunoreactivity once they had entered the lung mesenchyme (PV in Fig.  6B ). Similarly in the descending thoracic aorta we find no GATA-6 staining at any stages analysed here (Ao in Fig.  6A,B) . Again, the staining of blood cells within the aorta is artefactual. Thus the smooth muscle of the aortic system appears to be another tissue which demonstrates an apparent disparity between the expression of GATA-6 RNA and protein. In the caval veins however, we do see GATA-6 expression: the left superior vena cava is seen to be positive for GATA-6 close to its entry to the left atrium in day-15.5 embryos (SVC in Fig. 4A ).
1.6. GATA-6 is primarily associated with distal elements of the bronchial tree GATA-6 RNA has been shown to be expressed within the fetal pulmonary epithelium, and to be required for correct branching morphogenesis and epithelial differentiation Koutsourakis et al., 2001) . We similarly find GATA-6 protein to be expressed within the fetal lung, and to be associated with the most distal elements of the developing pulmonary system. Thus in day-11.5 embryos the trachea and proximal elements of the principle bronchi remain unlabelled (Tr in Fig. 6A and data not A. Brewer et al. / Mechanisms of Development 119S (2002) S121-S129 S126 Fig. 9 . GATA-6 in the AGM. (A) Sections through the AGM of embryos at day 12.5. In addition to staining in and around the notochord (N), GATA-6 is also seen in the gonadal (G) but not metanephric (M) parts of the UGR. A few labelled cells are also seen in the dorsal mesentery (asterisk) between the caudal tips of the lung buds (Lu) and more extensively in and around the ventrolateral walls of the aorta (A). Extensive labelling is also seen between the aorta and UGR (arrows) which represents the site of the adrenal primordia. (B) Enlargement of a serial section representing boxed area in (A) showing continuity of staining between the ventrolateral aortic wall and the UGR.
shown). However, expression can be detected in the epithelia of the distal parts of the principal bronchi where they are surrounded by the mesenchyme of the lung bud (Br in Fig.  6B ) By day-15.5, GATA-6 similarly appears to be confined to the epithelia of the more distal elements of the respiratory tract. Thus at this stage, the segmental bronchi are stained (Br in Fig. 6C ), while the lobar bronchi are unlabeled (black arrows in Fig. 6C) . The boundary of GATA-6 expression can clearly be seen at the transition where this branching is initiated (white arrows in Fig. 6C ). These observations are in agreement with previous expression studies in which GATA-6 RNA is initially detected at the tips of the growing lung buds, and by day 15.5 in the endoderm lining the growing airways ).
GATA-6 is not uniformly expressed throughout the gut epithelia
In situ hybridization studies have also demonstrated the embryonic gut to be a major site of GATA-6 expression (Morrisey et al., 1996) and accordingly, we can detect GATA-6 protein within the developing gut epithelium, although in a non-uniform fashion. Firstly, expression is apparent in the oesophageal epithelia at all stages studied here, i.e. from 11.5-to 15.5-day mouse embryos (Oes in Figs. 6 and 7) . As development proceeds, the circular smooth muscle (SM) which starts to surround the oesophagus is also seen to express GATA-6 (Fig. 7) . However, in the gut epithelia of the distal foregut, close to or at the gastro-oesophageal junction, there is a marked decrease in GATA-6 staining, seen in 12.5-day mouse embryos (arrow in Fig. 7A ). Thus the epithelia lining the lumen of the stomach (L) and the smooth muscle surrounding it are seen to stain much more weakly than the oesophagus at this stage. More caudally, midgut elements of the small intestine are seen to express GATA protein (G in Fig.  8C ), but the hindgut remained unstained (data not shown). GATA-6 expression along the length of the gut epithelium is therefore very dynamic, and in at least one region (the gastro-oesophageal junction) there is a clear boundary between higher-and lower-expressing cells.
GATA-6 in the AGM
It has previously been demonstrated (Morrisey et al., 1996; Brewer et al., 1999 ) that GATA-6 RNA can be detected in the urogenital ridge (UGR) during murine embryogenesis. Consistent with this, we find GATA-6 immunoreactivity in the UGR of day-12.5 mouse embryos (Fig. 9) . Furthermore, it is clear that labeling is restricted to the medial aspect of the ridge, representing the site of the prospective gonads rather than laterally where the metanephros is forming (the mesonephros having largely regressed by this stage). GATA-6 positive cells are also seen within the ventrolateral surface of the aorta and the posterior body wall between the dorsal aorta and the UGR (A and arrowed in Fig. 9 ). This general domain of the embryo is termed the aorta-genital ridge-mesonephric region (AGM), and diverse populations of migratory cells are contained within it. These include primordial germ cells (PGCs), haematopoietic stem cells and neural crest which will contribute to the adrenal primordial and subaortic ganglia. However, most PGCs have already entered the developing gonads by embryonic day 12.5 (Tam and Snow, 1981) while de novo production of haematopoietic stem cells occurs between embryonic days 9.5 and 12.5 (Muller et al., 1994; Medvinsky and Dzierzak, 1996) . A possible haematopoietic identity of the GATA-6-expressing cells in the AGM is supported by expression in the ventrolateral aortic wall and that we have also previously noted the expression of Xenopus GATA-6 RNA within the haematopoietic precursors of the ventral blood islands (Gove et al., 1997) . Clearly, positive identification of the cell types here requires confirmation by the use of additional molecular markers and this work is currently in progress.
GATA-6 and sites of chondrogenesis
It was evident from examination of our stained embryo sections, that GATA-6 expression was more widespread than had been shown previously. For instance, in 11.5-and 12.5-day embryos high levels of GATA-6 protein are detected within elements of the head mesenchyme (arrow in Fig. 8A , and BAI and NP in Fig. 8C ). As with other expression patterns described here, all expression domains were identified by (at least) two different GATA-6 antisera, confirming specificity. The pattern of staining seen in day-11.5 embryos is characteristic of late-migrating cranial neural crest cells which have colonized the head mesenchyme (Fig. 8A) . These cells will later form (in part) the bones of the viscerocranium. Moreover at day-12.5 GATA-6 staining is seen within the cartilaginous primordia of the mandibular component of the first branchial arch (BAI in Fig. 8B ), and the lateral nasal process (NP in Fig. 8B ) demonstrating a novel association of GATA-6 and sites of chondrogenesis. The first branchial arch differentiates into its terminal structures at about embryonic day 15.5 and at this time extensive mature cartilaginous "bars" are seen throughout the head (data not shown). In addition, we find that GATA-6 protein is abundant in the sclerotome of day-12.5 embryos, where we have also previously detected GATA-6 RNA (unpublished data) and in the notochord (N in Figs. 8C and 9A) . At this stage, the notochord is degenerating and will later become the nucleus pulposus, the centre of the future intervertebral disc. The cells surrounding the notochord are sclerotome-derived and will form the remainder of the intervertebral disc and the vertebral body. These cells also contain GATA-6 protein (Fig. 9A) .
At present, no other GATA factor has been shown to be associated with skeletal elements although we have previously detected GATA-6 RNA in murine sclerotome by in situ hybridization (unpublished results). There are different populations of sclerotome-derived cells, which take different migratory pathways, and give rise to distinct structures. Thus one population will form the vertebral bodies and intervertebral discs, while another will form the vertebral arches. The two populations can be distinguished in the undulated mouse expressed (a Pax-1 mutant), where vertebral bodies and intervertebral discs are malformed while the arches are essentially normal (Wallin et al., 1994) . Moreover, the different cell types can be distinguished here by GATA-6 expression, which is confined to the cells which will give rise to the vertebral bodies and intervertebral discs, and is not evident in cells corresponding to the vertebral arch precursors Clearly, GATA-6 encodes a much larger protein than previously appreciated which is also much more widely expressed during murine embryogenesis.
Experimental procedures
2.1. Generation of GATA-6-specific antibodies GATA-6 cDNA fragments were generated by PCR, using primers incorporating suitable restriction sites and cloned into a pGex5X-3 vector (Amersham-Pharmacia) with a modified multiple cloning site (McNamara and Ford, 2000) . Fragment A in Fig. 1 represents the entire region between the two putative methionine residues within mouse GATA-6 (Brewer et al., 1999) . Fragment B corresponds to amino acids 188-373 of the mouse GATA-6 protein (Brewer et al., 1999) and fragment C the 60 most C-terminal amino acid residues of the rat GATA-6 protein . Expression clones were transformed into Top 10 cells (Invitrogen) and induced under standard conditions to overexpress the GST fusion proteins. In the first two cases described above, the desired products were purified as insoluble inclusion bodies. A detailed protocol is available on request (A.B.).
Each partially-purified fusion product in HBSS was mixed 1:1 with Freund's complete (for first injection) or incomplete adjuvant and used to immunize New Zealand White rabbits. Immunizations contained 1.0 mg of fusion construct preparation and were delivered by subcutaneous and intramuscular routes and repeated at 2-week intervals for a total of 6 weeks. Test bleeds were taken before immunization and at 3 weeks and 5 weeks after the first injection. Rabbits were exsanguinated under anaesthesia after 8 weeks.
Immunoprecipitation
The specificity of two of the antisera generated was determined by immunoprecipitation. Undiluted aliquots of the antisera were bound to Affigel (BioRad) according to the manufacturer's specifications.
35
S-radiolabelled, truncated mouse GATA-6 polypeptides were generated in vitro by the TNT kit (Promega) using a construct, pMIa-II, which gives rise to polypeptides resulting from both putative methionine initiator codons in approximately equal amounts (Brewer et al., 1999) . Fifty-microlitre aliquots of the antibody-coupled Affigel slurry were added to a 25-ml TNT reaction which had been diluted into 750 ml PBS containing protease inhibitors (Sigma), and were incubated at 4 8C for 1 h with agitation. The slurry was pelleted at 5000 rpm, for 30 s at 4 8C, and washed 5 £ 15 min in PBS containing 0.05% Tween at 4 8C. Samples were subsequently boiled and run on standard SDS-PAGE gels, which were vacuum-dried before direct exposure to X-ray film.
Immunocytochemistry
T0 mouse embryos or decidua were fixed overnight at 4 8C in 4% paraformaldehyde, dehydrated and prepared for paraffin sectioning. Six-micrometre paraffin sections were cut, blocked for 45 min with rabbit serum and then incubated in primary antibody at 4 8C overnight. Antibodies directed against regions A, B and C (Fig. 1) were used at concentrations of 1:5000, 1:2000 and 1:200, respectively. Detection was performed using ABC and Vector Stain kits (Vector Laboratories).
Western blotting
Nuclei were prepared from adult mouse ventricles essentially as described (Gorski et al., 1986 ). The nuclear pellet was suspended in 2£ SDS gel-loading buffer and boiled for 10 min. Protein samples were prepared from other tissues as described previously (Brewer et al., 1999) . Membranes were exposed directly to X-ray film for the detection of [ 35 S]methionine-radiolabelled GATA-6 polypeptides generated in vitro by the TNT kit (Promega). These lanes were then cropped from the membrane, prior to ECL detection by Western blotting using an antibody raised against a C-terminal peptide (residues Thr 383-Ala 441 of the rat GATA-6 sequence; kind gift of Masatomo Maeda), again as previously described (Brewer et al., 1999; Nakagawa et al., 1997) .
